Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,755 public trials 967 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

Ability of Cardio Q for Prediction of Hypotension

NCT03882697

Conditions
Cardiovascular Diseases, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Severance Hospital, Yonsei University College of Medicine Seoul, South Korea
  • Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine Seoul, South Korea
View Trial Details
Completed

Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate Cancer

NCT01646684

Conditions
Castration Resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +8 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Dresden, Germany
  • Novartis Investigative Site Hamburg, Germany
  • Novartis Investigative Site Tübingen, Germany
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer

NCT03348527

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Nova Scotia Health Authority Halifax, Nova Scotia, Canada
  • Jonathan Giddens Medicine Professional Corporation Brampton, Ontario, Canada
  • G. Kenneth Jansz Medicine Professional Corporation Burlington, Ontario, Canada
  • The Fe/Male Health Centres Oakville, Ontario, Canada
View Trial Details
Completed

A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer

NCT00663832

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Novartis Investigative Site Rockville, Maryland, United States
  • Novartis Investigative Site Detroit, Michigan, United States
  • Novartis Investigative Site St Louis, Missouri, United States
  • Novartis Investigative Site Las Vegas, Nevada, United States
View Trial Details
Completed

Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer

NCT01338831

Conditions
Breast Diseases, Breast Neoplasms, Castration-resistant Prostate Cancer, +19 more
Locations
  • Massachusetts General Hospital Mass Gen 3 Boston, Massachusetts, United States
  • Cancer Institute of New Jersey SC New Brunswick, New Jersey, United States
  • Thomas Jefferson University, Dept. of Phsyciatry & Neurology Thomas Jefferson Philadelphia, Pennsylvania, United States
  • University of Utah / Huntsman Cancer Institute Huntsman 3 Salt Lake City, Utah, United States
View Trial Details
Completed

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

NCT00411528

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of California San Diego Dept of Moores Cancer Center La Jolla, California, United States
  • University of Colorado Dept. of Univ. of Colorado Aurora, Colorado, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Georgetown University/Lombardi Cancer Center Dept.of Lombardi Cancer Center Washington D.C., District of Columbia, United States
View all 32 locations
View Trial Details

Related conditions